See the DrugPatentWatch profile for dayvigo
Is Dayvigo Safe with Sleep Apnea?
No, you should not take Dayvigo (lemborexant) if you have sleep apnea. The prescribing information explicitly contraindicates it in patients with moderate or severe obstructive sleep apnea (OSA) due to risks of respiratory depression and further airway obstruction during sleep.[1] Lemborexant, an orexin receptor antagonist, can suppress arousal mechanisms that help maintain breathing in sleep apnea patients.
Why Is It Contraindicated?
Dayvigo reduces wakefulness by blocking orexin, which may worsen apnea events by impairing the brain's ability to respond to low oxygen or high CO2 levels. Clinical trials excluded patients with moderate/severe OSA, but data in mild OSA showed no major issues at approved doses (5 mg or 10 mg). Still, the FDA label bans it for moderate/severe cases to avoid exacerbating central or obstructive apnea.[1][2]
What If You Have Mild Sleep Apnea?
Limited data suggest Dayvigo may be tolerable in mild OSA, but only under close medical supervision with monitoring like pulse oximetry. Consult your doctor for a sleep study review; they might adjust CPAP settings or opt for alternatives.[1]
Alternatives for Sleep Apnea Patients
- Ramelteon (Rozerem): Melatonin agonist; safer profile in OSA as it avoids respiratory suppression.[3]
- Low-dose doxepin (Silenor): Approved for sleep maintenance; minimal impact on breathing.[3]
- Behavioral options: CBT-I or CPAP optimization often preferred over meds.
Avoid other orexin antagonists like Belsomra (suvorexant), which carry similar OSA warnings.[1]
Next Steps and Doctor Input
See a sleep specialist before starting any sleep aid. Untreated apnea plus Dayvigo raises risks of hypoxia, heart strain, or sudden worsening. Share your apnea severity (AHI score) and current treatments.
Sources:
[1]: Dayvigo Prescribing Information (FDA)
[2]: Eisai Dayvigo Safety Profile
[3]: American Academy of Sleep Medicine Guidelines